DelveInsight launched a new report on CDKL5 Deficiency Disorder Epidemiology Forecast, 2030.
Cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (CDD) is a rare developmental epileptic encephalopathy (DEE) caused by changes (mutations) in the CDKL5 gene. CDD has been classified as a DEE because the genetic change causes both epileptic activities as well as severe impairment of development.
DelveInsight’s ‘CDKL5 Deficiency Disorder Epidemiology Forecast to 2030‘ report delivers an in-depth understanding of the disease, historical and forecasted CDKL5 Deficiency Disorder epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Some of the key highlights from the CDKL5 Deficiency Disorder Epidemiology Report:
As per an organization, CDKL5 mutations have been identified in many ethnic groups, with more females than males being reported with an approximate ratio of 4:1.
As per DelveInsight’s estimation, there were 16,511 prevalent cases of CDKL5 in the 7MM in 2020. Out of this, the maximum cases were contributed by the US (6,138 in 2020).
As per the US National Library of Medicine, more than 1,000 cases have been reported worldwide.
In 2020, there were 3,944 diagnosed prevalent cases of CDD in the 7MM.
Visit for more @ CDKL5 Deficiency Disorder Epidemiology Insights
Scope of the CDKL5 Deficiency Disorder Epidemiology report:
The CDKL5 Deficiency Disorder report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis, and treatment patterns
The CDKL5 Deficiency Disorder Epidemiology Report and Model provide an overview of the risk factors and global trends of CDKL5 Deficiency Disorder in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan)
The report provides insight into the historical and forecasted patient pool of CDKL5 Deficiency Disorder in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
The report helps to recognize the growth opportunities in the 7MM concerning the patient population
The report assesses the disease risk and burden and highlights the unmet needs of CDKL5 Deficiency Disorder
The report provides the segmentation of the CDKL5 Deficiency Disorder epidemiology
Table of Contents:
1. Key Insights
2. Executive Summary of CDKL5 Deficiency Disorder
3.CDKL5 Deficiency Disorder Epidemiology Overview at a Glance
4.CDKL5 Deficiency Disorder: Disease Background and Overview
5. Epidemiology and Patient Population
6. Case Reports
7. Country Wise-Epidemiology of CDKL5 Deficiency Disorder
9. DelveInsight Capabilities
11. About DelveInsight
DelveInsight’s ‘CDKL5 Deficiency Disorder-Market Insights, Epidemiology, and Market Forecast—2030’ report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom),
“CDKL5 Deficiency Disorder Pipeline Insight, 2021” report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the CDKL5 Deficiency Disorder market. A detailed picture of the CDKL5 Deficiency Disorder pipeline landscape is provided, which includes the disease overview and CDKL5 Deficiency Disorder treatment guidelines.
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Address:304 S. Jones Blvd #2432
City: Las Vegas
Country: United States